Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
about
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised coEpidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial.Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.Colorectal cancer treatmentModeling the relationship between progression-free survival and overall survival: the phase II/III trial.Obesity is an independent prognostic variable in colon cancer survivors.The impact of delayed chemotherapy on its completion and survival outcomes in stage II colon cancer patients.Exploiting novel molecular targets in gastrointestinal cancers.Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer.Personalized colon cancer care in 2010.Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects.Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.Chemotherapy use in stage III colon cancer: a National Cancer Database analysisAdjuvant therapies for colorectal cancer.Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.Effects of 5-fluorouracil adjuvant treatment of colon cancer.Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients.Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.Association Between Time (Initiation and Length) and Oncological Outcomes for the Patients with Colon Cancer Treated with Adjuvant ChemotherapyEndpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.Current status of adjuvant therapy for colon cancer.Progress and challenges in the adjuvant treatment of stage II and III colon cancers.Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor.Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection.Analysis of saliva samples from oncological patients treated with 5-fluorouracil and leucovorin calcium by scanning electron microscopy with energy dispersive system.Long-term survival benefits of adjuvant chemotherapy by decreasing incidence of tumor recurrence without delaying relapse in stage III colorectal cancer.Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.
P2860
Q30316930-49B51354-F710-47E3-984E-FB168E4E1EDAQ30317520-7410CDDF-6CA2-45C2-9579-8B90449B87E2Q33432452-F0A43CEE-0B6C-46D7-B823-641CB33FBF77Q33947455-B8ADC41D-602A-4EF5-A5A1-5EE4DE87115FQ34040130-9D5BA47D-11C9-4B39-9D52-6FD0D7B637EAQ34168070-CAC1936D-88CF-4351-A1FD-E7D4A7143E7BQ34216044-AD7E1DEF-7587-4C3F-B552-143CC19CFD5AQ34382777-CF68F7D2-6488-4C4A-BAF6-7D70B7116125Q34632080-E463C27D-D76F-4A3F-9EE5-E9CDA63EA2BAQ34663753-5A407561-E10A-466B-B835-1878A545D362Q34731381-E6F63254-A580-4644-B186-F028D09B035AQ35076279-20E126AA-2DF1-4C57-B4B5-F5CBE15FBABCQ35383595-6F307A34-AEDE-48BB-A698-EF1DDAE1D341Q35735849-73DB93DF-61E2-4C26-A3DB-BE680985B37BQ35978879-D0C918A4-E6C3-4156-85C9-AA37FBECFDCCQ36177963-BA9A0C99-E736-4582-8E52-382DA3A22507Q36306269-BE63DC28-2485-4DCE-AFC5-52E09A410B73Q36499247-069ACBF5-3073-49E0-85BF-12D3FCB869ACQ36609950-31E9A3EE-9F55-4DDE-9A33-5CD1134D8560Q36610474-020C7CC4-42A0-4827-8304-EAED50A65A78Q36643640-D9561FF8-7FD0-44B3-B969-77DA60A83DF7Q36862977-83936060-D54E-4D89-A1C1-02C28D9BF994Q37077225-D1BCFFCB-7430-4F2B-BF1E-B097F0BD6DA7Q37134442-392355F7-22E5-40A4-AD79-5E0E00402CC1Q37507061-B3AFEC09-A8FB-4254-A00F-BABC794E6E48Q37589137-34B22AC5-2B6E-4A28-9FAB-1918F651E628Q38002127-30FB2F54-8C1B-4023-83F9-8844B1F2BB9BQ43648730-40A3AD56-53FD-4057-AD93-F8C126476DC0Q44505124-ED8EFF8A-3012-49B1-879B-20E13B628B06Q45105112-38571BCC-5793-4557-A52D-5B9277DA3B19Q53255093-CC145D71-8678-43EA-91D4-B6648C5355BC
P2860
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Phase III Southwest Oncology G ...... gh-risk stage II colon cancer.
@en
Phase III Southwest Oncology G ...... gh-risk stage II colon cancer.
@nl
type
label
Phase III Southwest Oncology G ...... gh-risk stage II colon cancer.
@en
Phase III Southwest Oncology G ...... gh-risk stage II colon cancer.
@nl
prefLabel
Phase III Southwest Oncology G ...... gh-risk stage II colon cancer.
@en
Phase III Southwest Oncology G ...... gh-risk stage II colon cancer.
@nl
P2093
P356
P1476
Phase III Southwest Oncology G ...... gh-risk stage II colon cancer.
@en
P2093
Daniel G Haller
Elizabeth A Poplin
Geoffrey R Weiss
Jacqueline K Benedetti
John S Macdonald
Norman C Estes
Richard M Goldberg
Robert J Mayer
Saul E Rivkin
P304
P356
10.1200/JCO.2005.04.169
P407
P577
2005-03-01T00:00:00Z